Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 9;18(3):2654–2660. doi: 10.3892/ol.2019.10593

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Radspieler et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 5. — Regulation of Lamin-B1 in RCC cell lines upon etoposide treatment. Representative (A and E) Ki-67 and (C and G) Lamin-B1 staining of (A and C) etoposide treated and (E and G) untreated 769-P cells. (B, D, F and H) Corresponding positive cell count markup. Blue indicates negative nuclei; and red indicates positive nuclei. (I and J) Box plots demonstrating the differences in the etoposide response in RCC cell lines. RCC, renal cell carcinoma; Eto, etoposide; Ctrl, control.

Figure 5. — Regulation of Lamin-B1 in RCC cell lines upon etoposide treatment. Representative (A and E) Ki-67 and (C and G) Lamin-B1 staining of (A and C) etoposide treated and (E and G) untreated 769-P cells. (B, D, F and H) Corresponding positive cell count markup. Blue indicates negative nuclei; and red indicates positive nuclei. (I and J) Box plots demonstrating the differences in the etoposide response in RCC cell lines. RCC, renal cell carcinoma; Eto, etoposide; Ctrl, control.